References
- Ananth J: Clomipramine in obsessive-compulsive dis-order: A review. Psychosomatics 24:723–727, 1983
- Yaryura-Tobias JA, Neziroglu F, Bergman L: Clomi-pramine for obsessive-compulsive neurosis: An or-ganic approach. Curr Ther Res Clin Exp 20:541–548, 1976
- Pollack BG, Perei JM, Nathan RS, et al: Acute anti-depresant effect following pulse loading with intra-venous and oral clomipramine. Arch Gen Psychiatry 46:29–35, 1989
- Beaumont G: Drug interactions with clomipramine (Anafrani1). J Int Med Res 1:480–484, 1973
- Insel T, Roy B, Cohen R, et al: Possible development of serotonin syndrome in man. Am J Psychiatry 139:954–955, 1982
- Smego R, Durack D: The neuroleptic malignant syn-drome. Arch Intern Med 142:1183–1185, 1982
- Gronert GA: Malignant hyperthermia. Anesthesiol-ogy 53:395–423, 1980
- Sternbach H: The serotonin syndrome. Am J Psychia-try 148:705–713, 1991
- Mann SC, Caroff SN, Lazarus A: Pathogenesis of neu-roleptic malignant syndrome. Psychiatric Ann. 21: 175–180, 1991
- Loscher W, Witte U, Fredow G, et al: Pharmacodyn-amic effects of sertonin (5-HT) receptor ligands in pigs: Stimulation of 5-HT2 receptors induces malignant hy-perthermia. Naunyn Schmiedebergs Arch Pharmacol 341:483–493, 1990
- Freisen CM: Successful use of dantrolene sodium in human malignant hyperthermia syndrome. Can An-aes Soc J 26:319–321, 1979
- Murphy DL, Brand E, Goldman T, et al: Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment. J Nerv Ment Dis 164:129–134, 1977
- Thoren P. Asberg M, Bertilisson L, et al: Clomipra-mine treatment of obsessive-compulsive disorder: Biochemical aspects. Arch Gen Psychiatry 37:1289–1294, 1980
- Brennan D, MacManus M, Howe J, et al: Neuroleptic malignant syndrome without neuroleptics. Br J Psy-chiatry 152:578–579, 1988
- Staufenberg EF, Tantam D: Malignant hyperthemia syndrome in combined treatment. Br J Psychiatry 154: 577–578, 1989
- Kline SS, Mauro LS, Scala-Barnett DM, et al: Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death. Clin Pharm 8:510–514, 1989
- Pascual J, Combarros 0, Berciano J: Partial status epi-lépticas following a single dose of chlorimipramine in a patient on MAO-inhibitor treatment. Clin Neuro-pharmacol 10:565–567, 1987
- Lader M: Combined use of tricyclic antidepressants and monoamine oxidase inhibitors. J Clin Psychiatry 44[sec 21:20-24, 1983
- Kaplan RF, Feinglass NG, Webster W, et al: Phenel-zine overdose treated with dantrolene sodium. JAMA 255:642–644, 1986
- Curley FJ, Irwin RS: Disorders of temperature control. Part 2. Hyperthermia. In Rippe JM, Irwin RS, Al pert JS, et al (eds). Intensive Care Medicine. Boston, Little, Brown, 1991, pp 674–688